Published in Ann Rheum Dis on February 01, 1989
Can immunisation trigger rheumatoid arthritis? Ann Rheum Dis (1993) 0.84
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Immunisation of patients with rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis (1988) 1.07
The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol (1994) 3.82
Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum (1997) 2.90
Oligoarthritis--a presenting feature of occult coeliac disease. Br J Rheumatol (1992) 2.84
Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) (1981) 2.84
Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangiitis. Arthritis Rheum (1996) 2.20
Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum (2000) 2.12
Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med (1984) 1.88
Classical versus non-renal Wegener's granulomatosis. Q J Med (1994) 1.79
A randomized controlled study of post-injection rest following intra-articular steroid therapy for knee synovitis. Br J Rheumatol (1994) 1.79
Estimating the incidence of rheumatoid arthritis: trying to hit a moving target? Arthritis Rheum (1999) 1.78
Epidemiology of systemic vasculitis: changing incidence or definition? Semin Arthritis Rheum (1995) 1.73
Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective community-based study. Arthritis Rheum (2001) 1.71
The association of cigarette smoking with disease outcome in patients with early inflammatory polyarthritis. Arthritis Rheum (2001) 1.71
A district audit on the management of polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol (1994) 1.70
Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44. Am J Hum Genet (1999) 1.68
IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Clin Exp Immunol (1981) 1.66
Classification and epidemiology of systemic vasculitis. Br J Rheumatol (1994) 1.63
The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study. Rheumatology (Oxford) (2000) 1.59
Epidemiology of vasculitis in Europe. Ann Rheum Dis (2001) 1.58
An unusual cause of blindness in Wegener's granulomatosis. Rheumatology (Oxford) (1999) 1.54
Pyrophosphate arthropathy: a study of metabolic associations and laboratory data. Ann Rheum Dis (1982) 1.50
Wegener's granulomatosis in the elderly--unusual presentations and misdiagnosis. J Rheumatol (1994) 1.48
EULAR recommendations for the management of knee osteoarthritis. Ann Rheum Dis (2001) 1.44
Factor VIII related antigen in the assessment of vasculitis. Ann Rheum Dis (1987) 1.43
Sulphasalazine in rheumatoid arthritis: haematological problems and changes in haematological indices associated with therapy. Br J Rheumatol (1989) 1.41
Hug(h)e(s') ears: an unusual presentation of antiphospholipid syndrome. Ann Rheum Dis (1999) 1.38
Churg-Strauss syndrome in a district hospital. QJM (1998) 1.30
Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. Cancer Epidemiol Biomarkers Prev (1997) 1.27
Rectal biopsy in the diagnosis of systemic vasculitis. J Clin Pathol (1981) 1.25
Systemic vasculitis in a district general hospital 1972-1980: clinical and laboratory features, classification and prognosis of 80 cases. Q J Med (1982) 1.24
Steroid-responsive nephrotic syndrome and allergy: immunological studies. Arch Dis Child (1981) 1.24
Berger disease: Henoch-Schönlein syndrome without the rash. J Pediatr (1985) 1.23
IgG antiglobulins in rheumatoid arthritis and other arthritides: relationship with clinical features and other parameters. Ann Rheum Dis (1981) 1.23
Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe. Ann Rheum Dis (2001) 1.21
The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum (1993) 1.19
Vasculitis-aims of therapy. An overview. Rheumatology (Oxford) (2000) 1.17
Polyarteritis and the kidney. Q J Med (1987) 1.16
Problems in the assessment of disease activity in ankylosing spondylitis. Rheumatol Rehabil (1981) 1.10
The incidence of rheumatoid vasculitis in the Norwich Health Authority. Br J Rheumatol (1994) 1.09
On the Effect of Acids, Alkalis, and Neutral Salts on the Fermentative Activity and on the Rate of Multiplication of Yeast Cells. Biochem J (1907) 1.07
Treatment of rheumatoid arthritis with desferrioxamine. Q J Med (1986) 1.07
Granulomatous mastitis--a rare cause of erythema nodosum. Postgrad Med J (1987) 1.04
Wegener's granulomatosis--increased incidence or increased recognition? Br J Rheumatol (1996) 1.04
Benchmarking: the five year outcome of rheumatoid arthritis assessed using a pain score, the Health Assessment Questionnaire, and the Short Form-36 (SF-36) in a community and a clinic based sample. Ann Rheum Dis (2001) 1.03
Alterations in the antigenic constitution of renal glomerular capillaries accompanying the histological maturation of renal glomeruli in the rat. Ann Rheum Dis (1967) 1.02
Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway. Ann Rheum Dis (1989) 1.02
Pyrophosphate arthropathy: a clinical and radiological study of 105 cases. Ann Rheum Dis (1982) 1.01
Azathioprine and cyclophosphamide in the treatment of rheumatoid arthritis. Br J Rheumatol (1998) 1.01
Complement-activating rheumatoid-factor-containing complexes in patients with rheumatoid vasculitis. Ann Rheum Dis (1983) 0.99
The use of 'alternative treatments' by patients with rheumatoid arthritis. Rheumatol Int (1983) 0.98
Filaments in the division furrow of mouse mammary cells. J Cell Biol (1970) 0.98
Classification and epidemiology of the vasculitides. Baillieres Clin Rheumatol (1997) 0.98
Inflammatory polyarthritis in the community is not a benign disease: predicting functional disability one year after presentation. J Rheumatol (1996) 0.97
What proteins are present in polyethylene glycol precipitates from rheumatic sera? Ann Rheum Dis (1989) 0.97
A single infusion of bisphosphonate AHPrBP in the treatment of Paget's disease of bone. J Rheumatol (1994) 0.96
Jejunal mucosal immunoglobulins and complement in untreated coeliac disease. J Pathol (1977) 0.96
Levamisole and surgery in bronchial carcinoma patients: increase in deaths from cardiorespiratory failure. Thorax (1979) 0.93
Osteomyelitis presenting as a swollen elbow in a patient with the acquired immune deficiency syndrome. Ann Rheum Dis (1988) 0.93
Endothelial cell cytotoxicity in inflammatory vascular diseases--the possible role of oxidised lipoproteins. Ann Rheum Dis (1985) 0.92
Cutaneous vasculitis in a defined population--clinical and epidemiological associations. J Rheumatol (1998) 0.91
The arthropathy of the Muckle-Wells syndrome. Br J Rheumatol (1994) 0.90
Acute ulcerative acne conglobata (acne fulminans) with erythema nodosum. Clin Exp Dermatol (1977) 0.90
Presence of psoriasis does not influence the presentation or short-term outcome of patients with early inflammatory polyarthritis. J Rheumatol (1997) 0.89
Activation of complement-a mechanism for the inflammation in acne. Br J Dermatol (1979) 0.89
Behçet's disease with erosive arthritis. Ann Rheum Dis (1986) 0.88
Side effect profile of 200 patients with inflammatory arthritides treated with sulphasalazine. Drugs (1986) 0.88
Enalapril in Raynaud's phenomenon. J Clin Pharm Ther (1988) 0.87
Isolated nail fold vasculitis in rheumatoid arthritis. Ann Rheum Dis (1995) 0.87
Primary renal vasculitis in Norfolk--increasing incidence or increasing recognition? Nephrol Dial Transplant (2000) 0.86
Retinal vasculitis in rheumatoid arthritis. Br Med J (Clin Res Ed) (1981) 0.86
Anterior synovial rupture of ankle joint presenting as deep venous thrombosis. Br Med J (1979) 0.84
Donor site morbidity following osteocutaneous free fibula transfer. Br J Plast Surg (1990) 0.84
Precipitating antibodies to nuclear antigens in systemic vasculitis. Clin Exp Immunol (1984) 0.84
A new assay for IgG rheumatoid factor activity and its use to analyse rheumatoid factor reactivity with human IgG isotypes. Rheumatol Int (1985) 0.83
Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis. Clin Exp Immunol (1985) 0.83
Individual variation in the isotype profile of anti-histone autoantibodies in systemic lupus erythematosus. Clin Exp Immunol (1988) 0.82
Bronchospasm associated with anti-TNF treatment. Clin Rheumatol (2009) 0.81
Secondary health service care and second line drug costs of early inflammatory polyarthritis in Norfolk, UK. J Rheumatol (2000) 0.81
Persistent arthritis after human parvovirus B19 infection. Lancet (1993) 0.81
Takayasu's arteritis: a pathogenetic role for cytotoxic T lymphocytes? Clin Rheumatol (1986) 0.80
T6 antigen-positive cells in human labial salivary glands. Arch Oral Biol (1985) 0.80
On the Size of the Cells of Pleurococcus and Saccharomyces in Solutions of a Neutral Salt. Biochem J (1907) 0.80
Fenclofenac-induced selective IgA deficiency in rheumatoid arthritis. Br J Rheumatol (1985) 0.80
Multiple serum protein abnormalities in lichen myxoedematosus. Br J Dermatol (1969) 0.80
Do B cells influence disease progression in chronic synovitis? Lessons from primary hypogammaglobulinaemia. Rheumatology (Oxford) (2000) 0.79
Partial finger loss: an indicator of severe connective tissue disease with overlap features. Br J Rheumatol (1983) 0.79
Immunohistological studies, with anti-connective tissue and anti-immunoglobulin antisera, of the skin in lupus erythematosus and scleroderma. Br J Dermatol (1975) 0.78
Neoral--new cyclosporin for old? Br J Rheumatol (1997) 0.78
Acute systemic lupus erythematosus with fatal pneumonitis and disseminated intravascular coagulation. Ann Rheum Dis (1985) 0.78
Malignant 'angioendotheliomatosis'--(intravascular lymphomatosis) an unusual cutaneous lymphoma in rheumatoid arthritis. Br J Rheumatol (1993) 0.78
Plasma exchange in rheumatoid vasculitis. J Rheumatol (1981) 0.78
Detection of increased blood flow to the affected arm in repetitive strain injury with radionuclide and Doppler ultrasound studies. A case report. Clin Nucl Med (1995) 0.77
The definition for coexistent rheumatoid arthritis and systemic lupus erythematosus. Lupus (1995) 0.77
Treatment of vasculitis in rheumatoid arthritis. Ann Med Interne (Paris) (1994) 0.77
Vasculitis. Baillieres Clin Rheumatol (1995) 0.77
Immunohistological studies of the kidney in systemic lupus erythematosus and systemic sclerosis using antisera to IgG, C3, fibrin, and human renal glomeruli. Ann Rheum Dis (1974) 0.77
Fatal neutropenic enterocolitis associated with sulphasalazine therapy for rheumatoid arthritis. Br J Rheumatol (1992) 0.77
Personality and keratoconus. CLAO J (1990) 0.77
99Tcm-MDP blood-pool phase in the assessment of repetitive strain injury. Nucl Med Commun (1997) 0.77
Acute confusional state and hyponatraemia due to inappropriate antidiuretic hormone secretion in polyarteritis nodosa. Ann Rheum Dis (1988) 0.77